                         SEQUENCE LISTING

<110>  BURNHAM INSTITUTE FOR MEDICAL RESEARCH 
       PELLECCHIA, Maurizio
 
<120>  BI-DENTATE COMPOUNDS AS KINASE INHIBITORS

<130>  BURN1200-1WO

<150>  US 60/962,778
<151>  2007-07-31

<160>  16    

<170>  PatentIn version 3.4

<210>  1
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct

<400>  1

Arg Pro Thr Thr Leu Asn Leu Gly Gly 
1               5                   


<210>  2
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct

<400>  2

Pro Thr Thr Leu Asn Leu Gly Gly 
1               5               


<210>  3
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct

<400>  3

Leu Asn Leu Gly Gly 
1               5   


<210>  4
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct

<400>  4

Arg Pro Thr Thr Leu Asn Leu 
1               5           


<210>  5
<211>  21
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct

<400>  5

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Gly Gly Arg Pro Thr Thr 
1               5                   10                  15      


Leu Asn Leu Gly Gly 
            20      


<210>  6
<211>  21
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct

<400>  6

Gly Gly Leu Asn Leu Thr Thr Pro Arg Gly Gly Arg Arg Arg Gln Arg 
1               5                   10                  15      


Arg Lys Lys Arg Gly 
            20      


<210>  7
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct

<400>  7

Gly Arg Pro Thr Thr Leu Asn Leu Gly Gly 
1               5                   10  


<210>  8
<211>  21
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct


<220>
<221>  misc_feature
<222>  (1)..(8)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (14)..(21)
<223>  Xaa can be any naturally occurring amino acid

<400>  8

Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Leu Asn Leu Gly Gly Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa 
            20      


<210>  9
<211>  19
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct


<220>
<221>  misc_feature
<222>  (1)..(8)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (12)..(19)
<223>  Xaa can be any naturally occurring amino acid

<400>  9

Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Leu Asn Leu Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa 
            


<210>  10
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct

<400>  10

Pro Thr Thr Leu Asn Leu 
1               5       


<210>  11
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct

<400>  11

Gly Gly Leu Asn Leu Thr Thr Pro Arg 
1               5                   


<210>  12
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct

<400>  12

Gly Gly Leu Asn Leu Thr Thr Pro 
1               5               


<210>  13
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct

<400>  13

Gly Gly Leu Asn Leu 
1               5   


<210>  14
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct

<400>  14

Leu Asn Leu Thr Thr Pro Arg 
1               5           


<210>  15
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct

<400>  15

Leu Asn Leu Thr Thr Pro 
1               5       


<210>  16
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct

<400>  16

Arg Pro Lys Arg Pro Thr Thr Leu Asn Leu Phe 
1               5                   10      


